Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 80425-0340

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 80425-0340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 1 (Orphenadrine Citrate Er 100mg 80425 0340 01)

ORPHENADRINE CITRATE ER 100MG TABLET label showing extended release oral tablet strength of 100 mg, packed by Advanced Rx Pharmacy of Tennessee, LLC. The label includes storage instructions, comparison to Norflex with NDC 80425-0340-01, lot number 30ORP100724, and expiration date 7/31/2024. It also displays a barcode and pharmacy information for Gavis Pharmaceu.*

FDA Label Image

Image (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 01)

Chemical structure of Orphenadrine Citrate, showing the molecular formula with aromatic rings, ether, tertiary amine, and citrate components. This diagram represents the active ingredient Orphenadrine Citrate as used in the 100 mg extended release tablet by Advanced Rx Pharmacy of Tennessee, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.